Palliative Radiation Therapy for Head and Neck Cancers

Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potenti...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 105; no. 2; pp. 254 - 266
Main Authors Grewal, Amardeep S., Jones, Joshua, Lin, Alexander
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen. An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies.
AbstractList Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen. An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies.
Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the complexity and severity of their presenting symptoms. Palliative radiation therapy, along with other systemic and surgical measures, has the potential to significantly improve the quality of life of such patients. There is little high-level evidence and a lack of consensus to direct the selection of an optimal palliative radiation regimen. An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life. This review presents the treatment approaches, outcomes, and toxicities associated with different radiation regimens and proposes a multidisciplinary framework for the selection of an individualized treatment regimen for patients that centers around patient prognosis, goals of care, logistics of treatment, and the availability of other surgical and systemic therapies.
Author Grewal, Amardeep S.
Lin, Alexander
Jones, Joshua
Author_xml – sequence: 1
  givenname: Amardeep S.
  surname: Grewal
  fullname: Grewal, Amardeep S.
– sequence: 2
  givenname: Joshua
  surname: Jones
  fullname: Jones, Joshua
– sequence: 3
  givenname: Alexander
  surname: Lin
  fullname: Lin, Alexander
  email: alexander.lin@uphs.upenn.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31128145$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1Lw0AQhhep2A_9ByI5ekmczX4kuQhS1ApFRSp4WzabCW5Mk7qbFvrvTUn16Gnm8LzzMs-UjJq2QUIuKUQUqLypIlu5Nt9EMdAsAhFBzE_IhKZJFjIhPkZkAkxCyHp4TKbeVwBAacLPyJhRGqeUiwmRr7qure7sDoM3XRy2tglWn-j0Zh-UrQsWqItAN0XwjOYrmOvGoPPn5LTUtceL45yR94f71XwRLl8en-Z3y9DwhHdhJgEE5rGQLDOMiTwvBaayRANoUtA651TyAnWS9AwUJs9Tg5Kb1MgMTclm5Hq4u3Ht9xZ9p9bWG6xr3WC79SqOWUyppJnoUT6gxrXeOyzVxtm1dntFQR2MqUoNxtTBmAKhemN97OrYsM3XWPyFfhX1wO0AYP_nzqJT3ljsLRTWoelU0dr_G34Ao5V_gw
CitedBy_id crossref_primary_10_1016_j_jphotobiol_2019_111578
crossref_primary_10_3390_diagnostics13010099
crossref_primary_10_1186_s12951_021_01131_9
crossref_primary_10_1016_j_ajoms_2024_01_011
crossref_primary_10_1016_j_otc_2022_12_004
crossref_primary_10_1002_hed_26342
crossref_primary_10_1016_j_biopha_2023_114485
crossref_primary_10_1016_j_amjoto_2023_104031
crossref_primary_10_1016_j_lfs_2020_118189
crossref_primary_10_4103_jrcr_jrcr_53_21
crossref_primary_10_1016_j_radonc_2020_05_020
crossref_primary_10_3389_fonc_2021_683042
crossref_primary_10_1002_hed_26648
crossref_primary_10_1016_j_ctro_2023_100633
crossref_primary_10_3389_fonc_2022_1032471
crossref_primary_10_1007_s00066_020_01672_2
crossref_primary_10_1016_j_adro_2022_101096
crossref_primary_10_1016_j_soc_2021_02_007
crossref_primary_10_14338_IJPT_20_00060_1
crossref_primary_10_1002_hed_27730
crossref_primary_10_1200_GO_23_00253
crossref_primary_10_3389_fonc_2023_1288695
crossref_primary_10_7759_cureus_22142
crossref_primary_10_1016_j_ijrobp_2022_03_034
crossref_primary_10_1007_s00520_024_08419_0
crossref_primary_10_3389_fonc_2021_761393
crossref_primary_10_1017_S1460396922000322
crossref_primary_10_3390_medicina57010006
crossref_primary_10_5794_jjoms_69_9
crossref_primary_10_1177_08258597211065676
crossref_primary_10_1021_acsnano_1c05891
crossref_primary_10_1097_DCC_0000000000000606
crossref_primary_10_3390_cancers14030588
crossref_primary_10_1016_j_anl_2024_04_005
crossref_primary_10_6004_jnccn_2020_7664
crossref_primary_10_1002_adhm_202400406
crossref_primary_10_12968_ijpn_2022_28_7_333
crossref_primary_10_1007_s11864_023_01073_4
crossref_primary_10_1136_bmjspcare_2021_002908
crossref_primary_10_1002_pro6_1086
crossref_primary_10_1002_hed_26555
crossref_primary_10_1166_mex_2023_2578
crossref_primary_10_1093_jjco_hyac013
crossref_primary_10_1002_hed_26819
crossref_primary_10_1016_j_canrad_2023_03_004
crossref_primary_10_36290_xon_2022_064
Cites_doi 10.1259/bjr.20140646
10.1016/j.ijrobp.2017.06.012
10.1016/j.radonc.2004.03.009
10.1016/j.clon.2010.09.006
10.1016/S0140-6736(18)31999-8
10.1016/j.joms.2011.02.063
10.21873/anticanres.11364
10.1016/S1368-8375(97)00073-0
10.1016/j.ijrobp.2017.04.017
10.1016/j.ijrobp.2008.09.022
10.1056/NEJMoa0802656
10.1126/sciimmunol.aag1266
10.4103/0973-1075.116709
10.1016/j.ijrobp.2016.01.039
10.1056/NEJMoa1809697
10.1002/lary.23657
10.1016/0360-3016(89)90120-X
10.1002/hed.20697
10.1016/j.coms.2014.01.001
10.1136/ewjm.172.5.310
10.2217/fon-2017-0468
10.4103/0973-1075.58460
10.1056/NEJMoa1602252
10.1002/hed.20894
10.1053/srao.2000.6593
10.1080/02841860902740899
10.3122/jabfm.2015.04.140301
10.1016/S1470-2045(14)71116-7
10.1056/NEJMoa1000678
10.1089/jpm.2006.0192
10.1200/JCO.2014.55.1937
10.1016/0360-3016(93)90012-K
10.4103/0019-509X.180847
10.1200/jco.2015.33.29_suppl.39
10.1016/j.ijrobp.2010.06.055
10.1016/j.oraloncology.2015.07.011
10.1056/NEJMoa0912217
10.1200/JCO.2006.07.9194
10.1016/j.amjoto.2018.01.011
10.1016/j.ijrobp.2010.08.029
10.1016/j.radonc.2007.10.020
10.1016/S0959-8049(00)00054-X
10.1016/j.ijrobp.2016.03.053
10.1016/j.radonc.2005.10.008
10.12788/jcso.0201
10.1016/j.ijrobp.2018.06.105
10.14338/IJPT-18-00003.1
10.1016/j.radonc.2008.06.007
10.1007/s00520-014-2421-y
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijrobp.2019.05.024
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage 266
ExternalDocumentID 10_1016_j_ijrobp_2019_05_024
31128145
S0360301619307461
Genre Journal Article
Review
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
1RT
1~5
4.4
457
4G.
53G
5RE
7-5
AAEDT
AAEDW
AAIAV
AALRI
AAWTL
AAXUO
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
AENEX
AEVXI
AFCTW
AFRHN
AFTJW
AGZHU
AHHHB
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
ALXNB
AMRAJ
BELOY
DU5
EBS
EFJIC
EJD
F5P
FDB
GBLVA
HED
HMO
IHE
J1W
KOM
LX3
M41
MO0
O9-
OC~
OO-
RIG
RNS
ROL
RPZ
SDG
SEL
SES
SSZ
UV1
XH2
Z5R
ZA5
~S-
ADVLN
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
.55
.GJ
29J
5VS
AAQFI
AAQQT
AAQXK
AAYXX
ABEFU
ADMUD
ADPAM
AFFNX
AFJKZ
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
FIRID
G-2
HMK
HVGLF
HX~
HZ~
NQ-
R2-
SAE
SEW
UDS
X7M
XPP
ZGI
7X8
ID FETCH-LOGICAL-c474t-96005eb25639c335bbf5e86fec0ec80aab4164dea772560dcbb8ce64c8c69ecf3
ISSN 0360-3016
IngestDate Fri Aug 16 03:53:06 EDT 2024
Thu Sep 26 17:04:15 EDT 2024
Sat Sep 28 08:31:59 EDT 2024
Fri Feb 23 02:14:57 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-96005eb25639c335bbf5e86fec0ec80aab4164dea772560dcbb8ce64c8c69ecf3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink http://www.redjournal.org/article/S0360301619307461/pdf
PMID 31128145
PQID 2232116195
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_2232116195
crossref_primary_10_1016_j_ijrobp_2019_05_024
pubmed_primary_31128145
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2019_05_024
PublicationCentury 2000
PublicationDate 2019-10-01
2019-10-00
20191001
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: 2019-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2019
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Mohanti, Umapathy, Bahadur, Thakar, Pathy (bib22) 2004; 71
Temel, Greer, Muzikansky (bib58) 2010; 363
Minatel, Gigante, Franchin (bib30) 1998; 34
Burtness B, Harrington KJ, Greil R, et al. KEYNOTE-048: Phase 3 study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Paper presented at: The European Society for Medical Oncology 2018 Congress. October 22, 2018; Munich, Germany.
Bernacki, Paladino, Lamas (bib45) 2015; 33
Ghoshal, Chakraborty, Moudgil, Kaur, Patel (bib12) 2009; 15
Ferris, Gillison, Harris (bib39) 2017; 35
Siddiqui, Patel, Khan (bib33) 2009; 74
Sun, Michel, Babin (bib56) 2018; 14
Bledsoe, Noble, Reddy (bib31) 2016; 36
Murthy, Kumar, Budrukkar, Gupta, Ghosh-Laskar, Agarwal (bib19) 2016; 53
Jang, Teng, Genden (bib2) 2013; 123
Finnegan, Bhatt, Shaughnessy (bib11) 2016; 14
Spencer, Harris, Wheeler (bib50) 2008; 30
Porceddu, Rosser, Burmeister (bib18) 2007; 85
Spiotto, Fu, Weichselbaum (bib44) 2016; 1
Carrascosa, Yashar, Paris, Larocca, Faught, Spanos (bib17) 2007; 10
Palma, Olson, Harrow (bib55) 2018; 2013
Chen, Vaughan, Narayan, Vijayakumar (bib7) 2008; 30
Al-mamgani, Tans, Van rooij, Noever, Baatenburg de jong, Levendag (bib29) 2009; 48
Kowalski, Carvalho (bib4) 2000; 36
Das, Thomas, Pal, Isiah, John (bib27) 2013; 19
Cohen, Soulieres, Le Tourneau (bib37) 2019; 393
Agarwal, Nemade, Murthy (bib28) 2008; 89
Ferris, Blumenschein, Fayette (bib38) 2016; 375
McDonald, Moore, Johnstone (bib53) 2012; 82
Powell, Gitau, Sumey (bib40) 2018; 36
Ma, Lok, Zong (bib15) 2018; 4
Phan, Sio, Nguyen (bib14) 2016; 96
Gamez, Agarwal, Hu, Lukens, Harrison (bib16) 2017; 37
Paliwal, Kumar-Patidar, Walke, Hirapara, Jain, Raj-Bardia (bib23) 2012; 5
Khan, Tjong, Raziee (bib34) 2015; 23
bib59
Christakis, Lamont (bib41) 2000; 172
Ghoshal, Patel, Mudgil, Bansal, Sharma (bib24) 2004; 10
Vargo, Ward, Caudell (bib35) 2018; 100
Ward, Riaz, Caudell (bib52) 2018; 100
Nieder, Milas, Ang (bib54) 2000; 10
Moore, Mehta (bib46) 2015; 38
Visneswaran, Williams (bib1) 2014; 26
Kancherla, Oksuz, Prestwich (bib26) 2011; 23
Lok, Jiang, Gutiontov (bib13) 2015; 51
Stevens, Huang, Fung (bib36) 2011; 81
Fortin, Khaouam, Filion, Nguyen-Tan, Bujold, Lambert (bib21) 2016; 95
Spanos, Guse, Perez, Grigsby, Doggett, Poulter (bib8) 1989; 17
Fakhry, Zhang, Nguyen-Tan (bib48) 2014; 32
bib60
Ali, Alam, Mannan, Asaduzzaman, Khan, Islam (bib25) 2010; 6
Ang, Harris, Wheeler (bib47) 2010; 363
Paris, Spanos, Lindberg, Jose, Albrink (bib9) 1993; 25
Rzenwnicki, Kordecki, Lukasiewicz, Janica, Pulawska-Stalmach, Kordecki (bib3) 2012; 77
Langer, Harris, Horwitz (bib51) 2007; 25
Balachandran, Gonen, Smith, DeMatteo (bib42) 2015; 16
Corry, Peters, Costa (bib10) 2005; 77
Kawaguchi, Sato, Yamada (bib32) 2012; 70
Velez, Wang, Hsu (bib49) 2018; 39
Nguyen, Doerwald-Munoz, Zhang (bib20) 2015; 88
Antonia, Villegas, Daniel (bib43) 2018; 379
Vermorken, Mesia, Rivera (bib5) 2008; 359
Shuman, Yang, Taylor (bib57) 2011
Ali (10.1016/j.ijrobp.2019.05.024_bib25) 2010; 6
Mohanti (10.1016/j.ijrobp.2019.05.024_bib22) 2004; 71
Ferris (10.1016/j.ijrobp.2019.05.024_bib38) 2016; 375
Das (10.1016/j.ijrobp.2019.05.024_bib27) 2013; 19
Visneswaran (10.1016/j.ijrobp.2019.05.024_bib1) 2014; 26
Ghoshal (10.1016/j.ijrobp.2019.05.024_bib24) 2004; 10
Agarwal (10.1016/j.ijrobp.2019.05.024_bib28) 2008; 89
Rzenwnicki (10.1016/j.ijrobp.2019.05.024_bib3) 2012; 77
Vargo (10.1016/j.ijrobp.2019.05.024_bib35) 2018; 100
Chen (10.1016/j.ijrobp.2019.05.024_bib7) 2008; 30
Ma (10.1016/j.ijrobp.2019.05.024_bib15) 2018; 4
Fakhry (10.1016/j.ijrobp.2019.05.024_bib48) 2014; 32
Ward (10.1016/j.ijrobp.2019.05.024_bib52) 2018; 100
Phan (10.1016/j.ijrobp.2019.05.024_bib14) 2016; 96
Velez (10.1016/j.ijrobp.2019.05.024_bib49) 2018; 39
Carrascosa (10.1016/j.ijrobp.2019.05.024_bib17) 2007; 10
Porceddu (10.1016/j.ijrobp.2019.05.024_bib18) 2007; 85
Al-mamgani (10.1016/j.ijrobp.2019.05.024_bib29) 2009; 48
Kawaguchi (10.1016/j.ijrobp.2019.05.024_bib32) 2012; 70
Spiotto (10.1016/j.ijrobp.2019.05.024_bib44) 2016; 1
Christakis (10.1016/j.ijrobp.2019.05.024_bib41) 2000; 172
Sun (10.1016/j.ijrobp.2019.05.024_bib56) 2018; 14
Antonia (10.1016/j.ijrobp.2019.05.024_bib43) 2018; 379
McDonald (10.1016/j.ijrobp.2019.05.024_bib53) 2012; 82
Temel (10.1016/j.ijrobp.2019.05.024_bib58) 2010; 363
Gamez (10.1016/j.ijrobp.2019.05.024_bib16) 2017; 37
Ferris (10.1016/j.ijrobp.2019.05.024_bib39) 2017; 35
Murthy (10.1016/j.ijrobp.2019.05.024_bib19) 2016; 53
Kowalski (10.1016/j.ijrobp.2019.05.024_bib4) 2000; 36
Paris (10.1016/j.ijrobp.2019.05.024_bib9) 1993; 25
Moore (10.1016/j.ijrobp.2019.05.024_bib46) 2015; 38
Ghoshal (10.1016/j.ijrobp.2019.05.024_bib12) 2009; 15
Shuman (10.1016/j.ijrobp.2019.05.024_bib57) 2011
Kancherla (10.1016/j.ijrobp.2019.05.024_bib26) 2011; 23
Bernacki (10.1016/j.ijrobp.2019.05.024_bib45) 2015; 33
Balachandran (10.1016/j.ijrobp.2019.05.024_bib42) 2015; 16
Lok (10.1016/j.ijrobp.2019.05.024_bib13) 2015; 51
Stevens (10.1016/j.ijrobp.2019.05.024_bib36) 2011; 81
Siddiqui (10.1016/j.ijrobp.2019.05.024_bib33) 2009; 74
10.1016/j.ijrobp.2019.05.024_bib6
Khan (10.1016/j.ijrobp.2019.05.024_bib34) 2015; 23
Cohen (10.1016/j.ijrobp.2019.05.024_bib37) 2019; 393
Spencer (10.1016/j.ijrobp.2019.05.024_bib50) 2008; 30
Fortin (10.1016/j.ijrobp.2019.05.024_bib21) 2016; 95
Finnegan (10.1016/j.ijrobp.2019.05.024_bib11) 2016; 14
Ang (10.1016/j.ijrobp.2019.05.024_bib47) 2010; 363
Langer (10.1016/j.ijrobp.2019.05.024_bib51) 2007; 25
Corry (10.1016/j.ijrobp.2019.05.024_bib10) 2005; 77
Nguyen (10.1016/j.ijrobp.2019.05.024_bib20) 2015; 88
Nieder (10.1016/j.ijrobp.2019.05.024_bib54) 2000; 10
Jang (10.1016/j.ijrobp.2019.05.024_bib2) 2013; 123
Spanos (10.1016/j.ijrobp.2019.05.024_bib8) 1989; 17
Paliwal (10.1016/j.ijrobp.2019.05.024_bib23) 2012; 5
Vermorken (10.1016/j.ijrobp.2019.05.024_bib5) 2008; 359
Palma (10.1016/j.ijrobp.2019.05.024_bib55) 2018; 2013
Minatel (10.1016/j.ijrobp.2019.05.024_bib30) 1998; 34
Powell (10.1016/j.ijrobp.2019.05.024_bib40) 2018; 36
Bledsoe (10.1016/j.ijrobp.2019.05.024_bib31) 2016; 36
References_xml – volume: 10
  start-page: 19
  year: 2004
  end-page: 23
  ident: bib24
  article-title: Palliative radiotherapy in locally advanced head and neck cancer-A prospective trial
  publication-title: Indian J Palliat Care
  contributor:
    fullname: Sharma
– volume: 4
  start-page: 10
  year: 2018
  end-page: 19
  ident: bib15
  article-title: Proton radiotherapy for recurrent or metastatic head and neck cancers with palliative quad shot
  publication-title: Int J Part Ther
  contributor:
    fullname: Zong
– volume: 71
  start-page: 275
  year: 2004
  end-page: 280
  ident: bib22
  article-title: Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study
  publication-title: Radiother Oncol
  contributor:
    fullname: Pathy
– volume: 363
  start-page: 733
  year: 2010
  end-page: 742
  ident: bib58
  article-title: Early palliative care for patients with metastatic non-small-cell lung cancer
  publication-title: N Engl J Med
  contributor:
    fullname: Muzikansky
– volume: 363
  start-page: 24
  year: 2010
  end-page: 35
  ident: bib47
  article-title: Human papillomavirus and survival of patients with oropharyngeal cancer
  publication-title: N Engl J Med
  contributor:
    fullname: Wheeler
– volume: 36
  start-page: 6010
  year: 2018
  ident: bib40
  article-title: Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN)
  publication-title: J Clin Oncol
  contributor:
    fullname: Sumey
– volume: 100
  start-page: 586
  year: 2018
  end-page: 594
  ident: bib52
  article-title: Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A multi-institution cohort study by the MIRI collaborative
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Caudell
– volume: 33
  start-page: 39
  year: 2015
  ident: bib45
  article-title: Delivering more, earlier, and better goals-of-care conversations to seriously ill oncology patients
  publication-title: J Clin Oncol
  contributor:
    fullname: Lamas
– volume: 82
  start-page: 1083
  year: 2012
  end-page: 1089
  ident: bib53
  article-title: Risk of carotid blowout after reirradiation of the head and neck: A systematic review
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Johnstone
– volume: 359
  start-page: 1116
  year: 2008
  end-page: 1127
  ident: bib5
  article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer
  publication-title: N Engl J Med
  contributor:
    fullname: Rivera
– volume: 96
  start-page: 30
  year: 2016
  end-page: 41
  ident: bib14
  article-title: Reirradiation of head and neck cancers with proton therapy: Outcomes and analyses
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Nguyen
– volume: 34
  start-page: 119
  year: 1998
  end-page: 122
  ident: bib30
  article-title: Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavorable prognostic factors and severe symptoms
  publication-title: Oral Oncol
  contributor:
    fullname: Franchin
– volume: 100
  start-page: 595
  year: 2018
  end-page: 605
  ident: bib35
  article-title: A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Caudell
– volume: 379
  start-page: 2342
  year: 2018
  end-page: 2350
  ident: bib43
  article-title: Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
  publication-title: N Engl J Med
  contributor:
    fullname: Daniel
– volume: 16
  start-page: 173
  year: 2015
  end-page: 180
  ident: bib42
  article-title: Nomograms in oncology- more than meets the eye
  publication-title: Lancet Oncol
  contributor:
    fullname: DeMatteo
– volume: 70
  start-page: 461
  year: 2012
  end-page: 472
  ident: bib32
  article-title: Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer
  publication-title: J Oral Maxillofac Surg
  contributor:
    fullname: Yamada
– volume: 30
  start-page: 281
  year: 2008
  end-page: 288
  ident: bib50
  article-title: Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
  publication-title: Head Neck
  contributor:
    fullname: Wheeler
– ident: bib60
  article-title: Proton re-irradiation for recurrent head and neck cancer
– volume: 88
  start-page: 20140646
  year: 2015
  ident: bib20
  article-title: 0-7-21 hypofractionated palliative radiotherapy: An effective treatment for advanced head and neck cancers
  publication-title: Br J Radiol
  contributor:
    fullname: Zhang
– volume: 85
  start-page: 456
  year: 2007
  end-page: 462
  ident: bib18
  article-title: Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial
  publication-title: Radiother Oncol
  contributor:
    fullname: Burmeister
– volume: 26
  start-page: 123
  year: 2014
  end-page: 141
  ident: bib1
  article-title: Epidemiological trends in head and neck cancer and aids in diagnosis
  publication-title: Oral Maxillofac Surg Clin North Am
  contributor:
    fullname: Williams
– volume: 37
  start-page: 685
  year: 2017
  end-page: 691
  ident: bib16
  article-title: Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the “QUAD-SHOT regimen
  publication-title: Anticancer Res
  contributor:
    fullname: Harrison
– volume: 10
  start-page: 877
  year: 2007
  end-page: 881
  ident: bib17
  article-title: Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen
  publication-title: J Palliat Med
  contributor:
    fullname: Spanos
– volume: 10
  start-page: 200
  year: 2000
  end-page: 209
  ident: bib54
  article-title: Tissue tolerance to reirradiation
  publication-title: Sem Radiat Oncol
  contributor:
    fullname: Ang
– volume: 30
  start-page: 1586
  year: 2008
  end-page: 1591
  ident: bib7
  article-title: Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme
  publication-title: Head Neck
  contributor:
    fullname: Vijayakumar
– volume: 5
  start-page: 178
  year: 2012
  end-page: 182
  ident: bib23
  article-title: Palliative hypo-fractionated radiotherapy in locally advanced head and neck cancer with fixed neck nodes
  publication-title: Iran J Cancer Prev
  contributor:
    fullname: Raj-Bardia
– volume: 23
  start-page: 1099
  year: 2015
  end-page: 1103
  ident: bib34
  article-title: Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients
  publication-title: Support Care Cancer
  contributor:
    fullname: Raziee
– volume: 77
  start-page: 137
  year: 2005
  end-page: 142
  ident: bib10
  article-title: The “QUAD SHOT”—a phase II study of palliative radiotherapy for incurable head and neck cancer
  publication-title: Radiother Oncol
  contributor:
    fullname: Costa
– volume: 23
  start-page: 141
  year: 2011
  end-page: 148
  ident: bib26
  article-title: The role of split-course hypofractionated palliative radiotherapy in head and neck cancer
  publication-title: (
  contributor:
    fullname: Prestwich
– volume: 48
  start-page: 562
  year: 2009
  end-page: 570
  ident: bib29
  article-title: Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment
  publication-title: Acta Oncol
  contributor:
    fullname: Levendag
– volume: 375
  start-page: 1856
  year: 2016
  end-page: 1867
  ident: bib38
  article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck
  publication-title: N Engl J Med
  contributor:
    fullname: Fayette
– volume: 89
  start-page: 51
  year: 2008
  end-page: 56
  ident: bib28
  article-title: Hypofractionated, palliative radiotherapy for advanced head and neck cancer
  publication-title: Radiother Oncol
  contributor:
    fullname: Murthy
– volume: 25
  start-page: 4800
  year: 2007
  end-page: 4805
  ident: bib51
  article-title: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911
  publication-title: J Clin Oncol
  contributor:
    fullname: Horwitz
– ident: bib59
  article-title: Study of proton SBRT and immunotherapy for reccurent/progressive locoregional or metastatic head and neck cancer
– volume: 81
  start-page: 958
  year: 2011
  end-page: 963
  ident: bib36
  article-title: Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Fung
– volume: 1
  start-page: 1266
  year: 2016
  ident: bib44
  article-title: The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
  publication-title: Science Immunol
  contributor:
    fullname: Weichselbaum
– volume: 14
  start-page: 29
  year: 2016
  end-page: 36
  ident: bib11
  article-title: Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: Institutional experience and review of palliative regimens
  publication-title: J Community Support Oncol
  contributor:
    fullname: Shaughnessy
– volume: 77
  start-page: 17
  year: 2012
  end-page: 21
  ident: bib3
  article-title: Palliative embolization of hemorrhages in extensive head and neck tumors
  publication-title: Pol J Radiol
  contributor:
    fullname: Kordecki
– volume: 14
  start-page: 877
  year: 2018
  end-page: 889
  ident: bib56
  article-title: Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC
  publication-title: Future Oncol
  contributor:
    fullname: Babin
– volume: 35
  start-page: 6011
  year: 2017
  ident: bib39
  article-title: Safety evaluation of nivolumab concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504
  publication-title: J Clin Oncol
  contributor:
    fullname: Harris
– volume: 123
  start-page: 1173
  year: 2013
  end-page: 1177
  ident: bib2
  article-title: Palliative surgery for head and neck cancer with extensive skin involvement
  publication-title: Laryngoscope
  contributor:
    fullname: Genden
– volume: 393
  start-page: 156
  year: 2019
  end-page: 167
  ident: bib37
  article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomized, open-label, phase 3 study
  publication-title: Lancet
  contributor:
    fullname: Le Tourneau
– volume: 2013
  start-page: S3
  year: 2018
  end-page: S4
  ident: bib55
  article-title: Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): Results of a randomized trial
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Harrow
– volume: 172
  start-page: 310
  year: 2000
  end-page: 313
  ident: bib41
  article-title: Extent and determinants of error in physicians’ prognoses in terminally ill patients
  publication-title: West J Med
  contributor:
    fullname: Lamont
– volume: 36
  start-page: 1032
  year: 2000
  end-page: 1037
  ident: bib4
  article-title: Natural history of untreated head and neck cancer
  publication-title: Eur J Cancer
  contributor:
    fullname: Carvalho
– volume: 38
  start-page: 498
  year: 2015
  end-page: 503
  ident: bib46
  article-title: The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers
  publication-title: J Am Board Fam Med
  contributor:
    fullname: Mehta
– volume: 53
  start-page: 138
  year: 2016
  end-page: 141
  ident: bib19
  article-title: Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers
  publication-title: Indian J Cancer
  contributor:
    fullname: Agarwal
– volume: 51
  start-page: 957
  year: 2015
  end-page: 962
  ident: bib13
  article-title: Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers
  publication-title: Oral Oncol
  contributor:
    fullname: Gutiontov
– volume: 95
  start-page: 647
  year: 2016
  end-page: 653
  ident: bib21
  article-title: Palliative radiation therapy for advanced head and neck carcinomas: A phase 2 study
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Lambert
– start-page: 144
  year: 2011
  ident: bib57
  article-title: End of life care among head and neck cancer patients
  publication-title: Otolaryngol Head Neck Surg
  contributor:
    fullname: Taylor
– volume: 19
  start-page: 93
  year: 2013
  end-page: 98
  ident: bib27
  article-title: Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer: CMC Vellore experience
  publication-title: Indian J Palliat Care
  contributor:
    fullname: John
– volume: 74
  start-page: 1047
  year: 2009
  end-page: 1053
  ident: bib33
  article-title: Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Khan
– volume: 25
  start-page: 657
  year: 1993
  end-page: 660
  ident: bib9
  article-title: Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Albrink
– volume: 6
  start-page: 5
  year: 2010
  ident: bib25
  article-title: Short course palliative radiotherapy in locally advanced squamous cell carcinoma of head and neck
  publication-title: J Armed Forces Med Coll
  contributor:
    fullname: Islam
– volume: 39
  start-page: 257
  year: 2018
  end-page: 260
  ident: bib49
  article-title: Prognostic significance of HPV status in re-irradiation of recurrent and second primary cancers of the head and neck
  publication-title: Am J Otolaryngol
  contributor:
    fullname: Hsu
– volume: 17
  start-page: 659
  year: 1989
  end-page: 661
  ident: bib8
  article-title: Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Poulter
– volume: 32
  start-page: 3365
  year: 2014
  end-page: 3373
  ident: bib48
  article-title: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma
  publication-title: J Clin Oncol
  contributor:
    fullname: Nguyen-Tan
– volume: 36
  start-page: 933
  year: 2016
  end-page: 939
  ident: bib31
  article-title: Split-course accelerated hypofractionated radiotherapy (SCHART): A safe and effective option for head and neck cancer in the elderly or infirm
  publication-title: Anticancer Res
  contributor:
    fullname: Reddy
– volume: 15
  start-page: 137
  year: 2009
  end-page: 140
  ident: bib12
  article-title: Quad shot: A short but effective schedule for palliative radiation for head and neck carcinoma
  publication-title: Indian J Palliat Care
  contributor:
    fullname: Patel
– volume: 88
  start-page: 20140646
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib20
  article-title: 0-7-21 hypofractionated palliative radiotherapy: An effective treatment for advanced head and neck cancers
  publication-title: Br J Radiol
  doi: 10.1259/bjr.20140646
  contributor:
    fullname: Nguyen
– ident: 10.1016/j.ijrobp.2019.05.024_bib6
– volume: 100
  start-page: 586
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib52
  article-title: Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A multi-institution cohort study by the MIRI collaborative
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.06.012
  contributor:
    fullname: Ward
– volume: 71
  start-page: 275
  year: 2004
  ident: 10.1016/j.ijrobp.2019.05.024_bib22
  article-title: Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2004.03.009
  contributor:
    fullname: Mohanti
– volume: 23
  start-page: 141
  year: 2011
  ident: 10.1016/j.ijrobp.2019.05.024_bib26
  article-title: The role of split-course hypofractionated palliative radiotherapy in head and neck cancer
  publication-title: Clin Oncol (R Coll Radiol).
  doi: 10.1016/j.clon.2010.09.006
  contributor:
    fullname: Kancherla
– volume: 393
  start-page: 156
  year: 2019
  ident: 10.1016/j.ijrobp.2019.05.024_bib37
  article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomized, open-label, phase 3 study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)31999-8
  contributor:
    fullname: Cohen
– volume: 70
  start-page: 461
  year: 2012
  ident: 10.1016/j.ijrobp.2019.05.024_bib32
  article-title: Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer
  publication-title: J Oral Maxillofac Surg
  doi: 10.1016/j.joms.2011.02.063
  contributor:
    fullname: Kawaguchi
– volume: 37
  start-page: 685
  year: 2017
  ident: 10.1016/j.ijrobp.2019.05.024_bib16
  article-title: Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the “QUAD-SHOT regimen
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11364
  contributor:
    fullname: Gamez
– volume: 34
  start-page: 119
  year: 1998
  ident: 10.1016/j.ijrobp.2019.05.024_bib30
  article-title: Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavorable prognostic factors and severe symptoms
  publication-title: Oral Oncol
  doi: 10.1016/S1368-8375(97)00073-0
  contributor:
    fullname: Minatel
– volume: 100
  start-page: 595
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib35
  article-title: A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.04.017
  contributor:
    fullname: Vargo
– volume: 74
  start-page: 1047
  year: 2009
  ident: 10.1016/j.ijrobp.2019.05.024_bib33
  article-title: Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.09.022
  contributor:
    fullname: Siddiqui
– volume: 359
  start-page: 1116
  year: 2008
  ident: 10.1016/j.ijrobp.2019.05.024_bib5
  article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802656
  contributor:
    fullname: Vermorken
– volume: 1
  start-page: 1266
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib44
  article-title: The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
  publication-title: Science Immunol
  doi: 10.1126/sciimmunol.aag1266
  contributor:
    fullname: Spiotto
– volume: 19
  start-page: 93
  year: 2013
  ident: 10.1016/j.ijrobp.2019.05.024_bib27
  article-title: Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer: CMC Vellore experience
  publication-title: Indian J Palliat Care
  doi: 10.4103/0973-1075.116709
  contributor:
    fullname: Das
– volume: 95
  start-page: 647
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib21
  article-title: Palliative radiation therapy for advanced head and neck carcinomas: A phase 2 study
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2016.01.039
  contributor:
    fullname: Fortin
– volume: 379
  start-page: 2342
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib43
  article-title: Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1809697
  contributor:
    fullname: Antonia
– volume: 5
  start-page: 178
  year: 2012
  ident: 10.1016/j.ijrobp.2019.05.024_bib23
  article-title: Palliative hypo-fractionated radiotherapy in locally advanced head and neck cancer with fixed neck nodes
  publication-title: Iran J Cancer Prev
  contributor:
    fullname: Paliwal
– volume: 123
  start-page: 1173
  year: 2013
  ident: 10.1016/j.ijrobp.2019.05.024_bib2
  article-title: Palliative surgery for head and neck cancer with extensive skin involvement
  publication-title: Laryngoscope
  doi: 10.1002/lary.23657
  contributor:
    fullname: Jang
– volume: 17
  start-page: 659
  year: 1989
  ident: 10.1016/j.ijrobp.2019.05.024_bib8
  article-title: Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/0360-3016(89)90120-X
  contributor:
    fullname: Spanos
– volume: 30
  start-page: 281
  year: 2008
  ident: 10.1016/j.ijrobp.2019.05.024_bib50
  article-title: Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
  publication-title: Head Neck
  doi: 10.1002/hed.20697
  contributor:
    fullname: Spencer
– volume: 26
  start-page: 123
  year: 2014
  ident: 10.1016/j.ijrobp.2019.05.024_bib1
  article-title: Epidemiological trends in head and neck cancer and aids in diagnosis
  publication-title: Oral Maxillofac Surg Clin North Am
  doi: 10.1016/j.coms.2014.01.001
  contributor:
    fullname: Visneswaran
– volume: 172
  start-page: 310
  year: 2000
  ident: 10.1016/j.ijrobp.2019.05.024_bib41
  article-title: Extent and determinants of error in physicians’ prognoses in terminally ill patients
  publication-title: West J Med
  doi: 10.1136/ewjm.172.5.310
  contributor:
    fullname: Christakis
– volume: 14
  start-page: 877
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib56
  article-title: Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC
  publication-title: Future Oncol
  doi: 10.2217/fon-2017-0468
  contributor:
    fullname: Sun
– volume: 15
  start-page: 137
  year: 2009
  ident: 10.1016/j.ijrobp.2019.05.024_bib12
  article-title: Quad shot: A short but effective schedule for palliative radiation for head and neck carcinoma
  publication-title: Indian J Palliat Care
  doi: 10.4103/0973-1075.58460
  contributor:
    fullname: Ghoshal
– volume: 375
  start-page: 1856
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib38
  article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1602252
  contributor:
    fullname: Ferris
– volume: 30
  start-page: 1586
  year: 2008
  ident: 10.1016/j.ijrobp.2019.05.024_bib7
  article-title: Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme
  publication-title: Head Neck
  doi: 10.1002/hed.20894
  contributor:
    fullname: Chen
– volume: 10
  start-page: 200
  year: 2000
  ident: 10.1016/j.ijrobp.2019.05.024_bib54
  article-title: Tissue tolerance to reirradiation
  publication-title: Sem Radiat Oncol
  doi: 10.1053/srao.2000.6593
  contributor:
    fullname: Nieder
– volume: 48
  start-page: 562
  year: 2009
  ident: 10.1016/j.ijrobp.2019.05.024_bib29
  article-title: Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment
  publication-title: Acta Oncol
  doi: 10.1080/02841860902740899
  contributor:
    fullname: Al-mamgani
– volume: 38
  start-page: 498
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib46
  article-title: The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers
  publication-title: J Am Board Fam Med
  doi: 10.3122/jabfm.2015.04.140301
  contributor:
    fullname: Moore
– volume: 77
  start-page: 17
  year: 2012
  ident: 10.1016/j.ijrobp.2019.05.024_bib3
  article-title: Palliative embolization of hemorrhages in extensive head and neck tumors
  publication-title: Pol J Radiol
  contributor:
    fullname: Rzenwnicki
– volume: 16
  start-page: 173
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib42
  article-title: Nomograms in oncology- more than meets the eye
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)71116-7
  contributor:
    fullname: Balachandran
– volume: 363
  start-page: 733
  year: 2010
  ident: 10.1016/j.ijrobp.2019.05.024_bib58
  article-title: Early palliative care for patients with metastatic non-small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1000678
  contributor:
    fullname: Temel
– volume: 10
  start-page: 877
  year: 2007
  ident: 10.1016/j.ijrobp.2019.05.024_bib17
  article-title: Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2006.0192
  contributor:
    fullname: Carrascosa
– volume: 36
  start-page: 6010
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib40
  article-title: Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN)
  publication-title: J Clin Oncol
  contributor:
    fullname: Powell
– start-page: 144
  year: 2011
  ident: 10.1016/j.ijrobp.2019.05.024_bib57
  article-title: End of life care among head and neck cancer patients
  publication-title: Otolaryngol Head Neck Surg
  contributor:
    fullname: Shuman
– volume: 32
  start-page: 3365
  year: 2014
  ident: 10.1016/j.ijrobp.2019.05.024_bib48
  article-title: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.55.1937
  contributor:
    fullname: Fakhry
– volume: 25
  start-page: 657
  year: 1993
  ident: 10.1016/j.ijrobp.2019.05.024_bib9
  article-title: Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/0360-3016(93)90012-K
  contributor:
    fullname: Paris
– volume: 53
  start-page: 138
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib19
  article-title: Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers
  publication-title: Indian J Cancer
  doi: 10.4103/0019-509X.180847
  contributor:
    fullname: Murthy
– volume: 33
  start-page: 39
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib45
  article-title: Delivering more, earlier, and better goals-of-care conversations to seriously ill oncology patients
  publication-title: J Clin Oncol
  doi: 10.1200/jco.2015.33.29_suppl.39
  contributor:
    fullname: Bernacki
– volume: 10
  start-page: 19
  year: 2004
  ident: 10.1016/j.ijrobp.2019.05.024_bib24
  article-title: Palliative radiotherapy in locally advanced head and neck cancer-A prospective trial
  publication-title: Indian J Palliat Care
  contributor:
    fullname: Ghoshal
– volume: 81
  start-page: 958
  year: 2011
  ident: 10.1016/j.ijrobp.2019.05.024_bib36
  article-title: Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2010.06.055
  contributor:
    fullname: Stevens
– volume: 51
  start-page: 957
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib13
  article-title: Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2015.07.011
  contributor:
    fullname: Lok
– volume: 363
  start-page: 24
  year: 2010
  ident: 10.1016/j.ijrobp.2019.05.024_bib47
  article-title: Human papillomavirus and survival of patients with oropharyngeal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0912217
  contributor:
    fullname: Ang
– volume: 25
  start-page: 4800
  year: 2007
  ident: 10.1016/j.ijrobp.2019.05.024_bib51
  article-title: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.07.9194
  contributor:
    fullname: Langer
– volume: 39
  start-page: 257
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib49
  article-title: Prognostic significance of HPV status in re-irradiation of recurrent and second primary cancers of the head and neck
  publication-title: Am J Otolaryngol
  doi: 10.1016/j.amjoto.2018.01.011
  contributor:
    fullname: Velez
– volume: 82
  start-page: 1083
  year: 2012
  ident: 10.1016/j.ijrobp.2019.05.024_bib53
  article-title: Risk of carotid blowout after reirradiation of the head and neck: A systematic review
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2010.08.029
  contributor:
    fullname: McDonald
– volume: 85
  start-page: 456
  year: 2007
  ident: 10.1016/j.ijrobp.2019.05.024_bib18
  article-title: Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2007.10.020
  contributor:
    fullname: Porceddu
– volume: 36
  start-page: 1032
  year: 2000
  ident: 10.1016/j.ijrobp.2019.05.024_bib4
  article-title: Natural history of untreated head and neck cancer
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(00)00054-X
  contributor:
    fullname: Kowalski
– volume: 96
  start-page: 30
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib14
  article-title: Reirradiation of head and neck cancers with proton therapy: Outcomes and analyses
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2016.03.053
  contributor:
    fullname: Phan
– volume: 36
  start-page: 933
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib31
  article-title: Split-course accelerated hypofractionated radiotherapy (SCHART): A safe and effective option for head and neck cancer in the elderly or infirm
  publication-title: Anticancer Res
  contributor:
    fullname: Bledsoe
– volume: 77
  start-page: 137
  year: 2005
  ident: 10.1016/j.ijrobp.2019.05.024_bib10
  article-title: The “QUAD SHOT”—a phase II study of palliative radiotherapy for incurable head and neck cancer
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2005.10.008
  contributor:
    fullname: Corry
– volume: 14
  start-page: 29
  year: 2016
  ident: 10.1016/j.ijrobp.2019.05.024_bib11
  article-title: Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: Institutional experience and review of palliative regimens
  publication-title: J Community Support Oncol
  doi: 10.12788/jcso.0201
  contributor:
    fullname: Finnegan
– volume: 35
  start-page: 6011
  year: 2017
  ident: 10.1016/j.ijrobp.2019.05.024_bib39
  article-title: Safety evaluation of nivolumab concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504
  publication-title: J Clin Oncol
  contributor:
    fullname: Ferris
– volume: 2013
  start-page: S3
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib55
  article-title: Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): Results of a randomized trial
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2018.06.105
  contributor:
    fullname: Palma
– volume: 4
  start-page: 10
  year: 2018
  ident: 10.1016/j.ijrobp.2019.05.024_bib15
  article-title: Proton radiotherapy for recurrent or metastatic head and neck cancers with palliative quad shot
  publication-title: Int J Part Ther
  doi: 10.14338/IJPT-18-00003.1
  contributor:
    fullname: Ma
– volume: 89
  start-page: 51
  year: 2008
  ident: 10.1016/j.ijrobp.2019.05.024_bib28
  article-title: Hypofractionated, palliative radiotherapy for advanced head and neck cancer
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2008.06.007
  contributor:
    fullname: Agarwal
– volume: 6
  start-page: 5
  year: 2010
  ident: 10.1016/j.ijrobp.2019.05.024_bib25
  article-title: Short course palliative radiotherapy in locally advanced squamous cell carcinoma of head and neck
  publication-title: J Armed Forces Med Coll
  contributor:
    fullname: Ali
– volume: 23
  start-page: 1099
  year: 2015
  ident: 10.1016/j.ijrobp.2019.05.024_bib34
  article-title: Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-014-2421-y
  contributor:
    fullname: Khan
SSID ssj0001174
Score 2.5652385
SecondaryResourceType review_article
Snippet Patients with advanced head and neck cancers who are not eligible for curative treatment represent a challenging cohort of patients to manage given the...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 254
SubjectTerms Cancer Pain - drug therapy
Cancer Pain - radiotherapy
Clinical Trials as Topic
Deglutition Disorders - therapy
Dose Fractionation, Radiation
Episode of Care
Head and Neck Neoplasms - complications
Head and Neck Neoplasms - mortality
Head and Neck Neoplasms - radiotherapy
Humans
Immunotherapy - methods
Oropharyngeal Neoplasms - virology
Palliative Care - methods
Papillomavirus Infections - complications
Physical Functional Performance
Prognosis
Proton Therapy
Radiation-Sensitizing Agents - therapeutic use
Radiotherapy - methods
Radiotherapy Dosage
Re-Irradiation
Treatment Outcome
Xerostomia - etiology
Title Palliative Radiation Therapy for Head and Neck Cancers
URI https://dx.doi.org/10.1016/j.ijrobp.2019.05.024
https://www.ncbi.nlm.nih.gov/pubmed/31128145
https://search.proquest.com/docview/2232116195
Volume 105
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZC2MvZe1u6baiwd6Giy1LvjyW0i5t02wUh-VNWLJMl9KkpAmF_vodXSy7dKWXFxMMFuGcj3O-cxVC3yURuqkxgSAnqgNgxCTIJauDVDvPSsa0MnnI01EyGNPjCZv0ekedrqXVUuzK2__OlbxEq_AO9KqnZJ-hWX8ovIDfoF94gobh-SQd_y51ssQ0_5zpHQNGl4XdE2D6BwegQVMeGCl58WNfa9hVb6ZtB3ubEOyskVj48-Yz6SdaRDvcYlMinpH_XKib0hb8LwF0Sl21SVV_H8Dx_Pp85f3A0K0vaEZsugmIKPetbOA_rNHM0jwA3jK5Y1VD1oEP6dpIuzXauVtiL125Z8ltUmG6-3e6mAu9WDTKzYpVQlvP1VTrR7_44Xg45MXBpHiF1gnYHDB263snZ39OvFuOIPZqZidNg9_9kx_iJg_FHoaDFG_Rhgse8J5FwibqqdkWen3q2iPeoaQFBPaAwA4QGACBNSAwSBtrQGAHiPdofHhQ7A8CdzFGIGlKlwFEnSFTAthqnMs4ZkLUTGVJrWSoZBaWpQCaTStVQugEjLaSQmRSJVRmMsmVrOMPaG0Gqv-EMJNVquooFCQFn6nyLE5oKanZX52ShPRR0IiEX9n9J7xpDJxyK0KuRchDxkGEfZQ2cuOOw1luxkGxj3z5rREzBxOn61blTM1X1xwYLIkgMslZH3208vf_JY50KZiy7Sd8_Rm9afH7Ba0tFyv1FSjlUuw4sPwDpP141A
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palliative+Radiation+Therapy+for+Head+and+Neck+Cancers&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Grewal%2C+Amardeep+S&rft.au=Jones%2C+Joshua&rft.au=Lin%2C+Alexander&rft.date=2019-10-01&rft.eissn=1879-355X&rft.volume=105&rft.issue=2&rft.spage=254&rft.epage=266&rft_id=info:doi/10.1016%2Fj.ijrobp.2019.05.024&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon